In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement

Sumant Samuel1, Binu S Mathew, Balaji Veeraraghavan

  • 1Department of Orthopedics (Unit III), Christian Medical College, Ida Scudder road, Vellore, 632004, TN, India. sumantsamuel@gmail.com

Abstract

Insights

High-dose meropenem in acrylic bone cement shows promising elution and bioactivity against resistant Gram-negative orthopaedic infections. Further in vivo studies are needed to confirm its efficacy.

Area of Science:

  • Orthopaedic Surgery
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic-loaded acrylic bone cement is a common treatment for orthopaedic infections.
  • Rising antibiotic resistance necessitates exploring alternative antibiotics like meropenem.
  • This study investigates meropenem-loaded bone cement's elution and bioactivity in vitro.

Purpose of the Study:

  • To evaluate the in vitro elution kinetics of meropenem from acrylic bone cement at various concentrations.
  • To assess the in vitro bioactivity of meropenem eluates against a panel of common orthopaedic pathogens.
  • To determine the potential of meropenem-loaded bone cement as a treatment for antibiotic-resistant infections.

Main Methods:

  • Acrylic bone cement cylinders loaded with different meropenem concentrations were prepared.
  • Elution kinetics were analyzed by measuring drug concentration in saline eluates over time using HPLC.
  • Bioactivity of meropenem eluates was tested against Staphylococcus aureus (MSSA and MRSA), Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae (ESBL).

Main Results:

  • Meropenem eluted from bone cement over 3-27 days, with higher concentrations yielding greater elution.
  • Meropenem eluates demonstrated bioactivity against MSSA, Pseudomonas aeruginosa, Escherichia coli, and ESBL Klebsiella pneumoniae for 3 weeks.
  • Elution patterns were consistent with typical antibiotic-loaded bone cement behavior.

Conclusions:

  • Meropenem elution from acrylic bone cement follows expected kinetics.
  • High-dose meropenem-loaded bone cement shows potential for treating resistant Gram-negative orthopaedic infections.
  • In vivo studies are required to validate the clinical effectiveness of meropenem-loaded bone cement.

Related Concept Videos